Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TScan Therapeutics (TCRX) Gains from Investment Securities (2020 - 2025)

TScan Therapeutics (TCRX) has disclosed Gains from Investment Securities for 6 consecutive years, with -$55000.0 as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities rose 96.45% to -$55000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.4 million through Dec 2025, up 38.18% year-over-year, with the annual reading at $6.2 million for FY2025, 49.89% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was -$55000.0 at TScan Therapeutics, up from -$291000.0 in the prior quarter.
  • The five-year high for Gains from Investment Securities was $6.4 million in Q4 2023, with the low at -$1.5 million in Q4 2024.
  • Average Gains from Investment Securities over 5 years is $847118.3, with a median of -$291000.0 recorded in 2025.
  • The sharpest move saw Gains from Investment Securities surged 108.9% in 2021, then plummeted 181.9% in 2025.
  • Over 5 years, Gains from Investment Securities stood at $3.0 million in 2021, then surged by 73.23% to $5.2 million in 2022, then increased by 23.3% to $6.4 million in 2023, then crashed by 124.03% to -$1.5 million in 2024, then soared by 96.45% to -$55000.0 in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at -$55000.0, -$291000.0, and -$786000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.